Management of Hypertension in Primary Care - Medscape
Aug 15, 2025 · Hypertension is the most common chronic condition that primary care physicians treat. Knowledge about the causes and effective treatment strategies have evolved over the …
Hypertension - Medscape
Nov 25, 2025 · Hypertension : Review in-depth clinical information, latest medical news, and guidelines on hypertension. Review signs of high blood pressure and causes of high blood …
Management of Hypertension in Chronic Heart Failure - Medscape
Hypertension (HTN) increases the risk of heart failure (HF) and it precedes it in 75 percent of cases. This article reviews essential HTN treatment in patients at risk for developing HF.
Comparison of the Effects of Nebivolol and Bisoprolol - Page 3
Cite this: Comparison of the Effects of Nebivolol and Bisoprolol on Systematic Vascular Resistance in Patients With Essential Hypertension - Medscape - Jun 01, 2002.
ICD-10: Coding for Hypertension and Heart Disease - Medscape
Aug 25, 2015 · There are some important elements to be aware of when coding for hypertension, heart disease, and kidney disease in ICD-10.
Secondary Hypertension: What to Look For - Medscape
Jul 16, 2025 · Cardiologist Dmitry Yaranov provides a brief but thorough roadmap for the workup of secondary hypertension.
Effects of Metformin on Blood Pressure - Medscape
Insulin resistance is associated with essential hypertension, independent of obesity.
Nighttime Dosing May Provide Better Blood Pressure Control
Jul 9, 2025 · Bedtime dosing of antihypertensive medication provided better control of nocturnal blood pressure and improved circadian rhythm without reducing efficacy of treatment.
Two Antihypertensives on Par for Renal Protection - Medscape
Dec 31, 2024 · Among patients with essential hypertension and high cardiovascular risk, reducing blood pressure (BP) appears to be more important than the specific antihypertensive agent …
Patients With Mild-to-Moderate Essential Hypertension - Medscape
Sep 1, 2001 · Essential hypertension represents an important cardiovascular risk factor in about 30% of the adult population in industrialised countries.